Literature DB >> 2323589

Relationship between gastrin cell number, serum, antral mucosa and luminal gastrin concentration and gastric acidity in antral atrophic gastritis.

F Marotta1, K Hayakawa, Y Mikami, P Morello, M Sugai, T Morita.   

Abstract

The aim of our study was to investigate the relationship between gastrin producing cell density with antral mucosa, luminal and serum gastrin concentration in antral atrophic gastritis. Our study group consisted of 17 patients: six with mild atrophic gastritis, seven with moderate atrophic gastritis and four with severe atrophic gastritis. None of the patients had type-A atrophic gastritis but the body mucosa was affected by superficial gastritis at various extent in some. A group of 15 healthy subjects served as control. All subjects underwent gastroscopic examination with multiple bioptic sampling. Radioimmunoassay was used for gastrin determination and photomicroscopy for gastrin producing cell density assessment. Electron microscopy was used to assess the gastrin producing granule density index. Patients with moderate and severe atrophic gastritis showed a lower gastric acidity and acid output as compared to control. Serum gastrin did not show significant differences among the groups. In moderate and severe atrophic gastritis, gastrin producing cell granule density index, gastrin producing cell density and antral mucosa gastrin concentration were significantly lower when compared with control and decreased with advancing of the severity of atrophic gastritis. In atrophic gastritis, however, the latter two measurements were not correlated. In moderate and severe atrophic gastritis luminal gastrin concentration significantly increased, compared with control, after the severity of atrophic gastritis. Gastrin producing cell granule density index and luminal gastrin concentration showed a significant correlation with gastric pH. These data suggest that in antral atrophic gastritis with reduced gastric acidity, the decrement of gastrin producing cells is followed by gastrin producing cell hyperfunction with increased luminal release of gastrin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323589      PMCID: PMC1378266          DOI: 10.1136/gut.31.3.279

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  pH dependence of acid secretion and gastrin release in normal and ulcer subjects.

Authors:  J H Walsh; C T Richardson; J S Fordtran
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

2.  Gastin cells and fasting gastrin levels in duodenal ulcer patients: a quantitative study based on multiple biopsy specimens.

Authors:  J Piris; R Whitehead
Journal:  J Clin Pathol       Date:  1979-02       Impact factor: 3.411

3.  Plasma-gastrin and acid secretion in patients with peptic ulceration.

Authors:  R I Wesdorp; J E Fischer
Journal:  Lancet       Date:  1974-10-12       Impact factor: 79.321

4.  The presence of gastrin in fasting and stimulated gastric juice of man.

Authors:  P H Jordan; B S Yip
Journal:  Surgery       Date:  1972-09       Impact factor: 3.982

5.  Hyperplasia of antral G cells in uraemic patients.

Authors:  F Carlei; U Caruso; E Lezoche; G Ruscitto; P Lackie; U Casciani; V Speranza; J M Polak
Journal:  Digestion       Date:  1984       Impact factor: 3.216

6.  Quantitative studies of gastrin cells (G cells) and parietal cells in relation to gastric acid secretion in patients with peptic ulcer disease.

Authors:  R Stave; J Myren; P Brandtzaeg; E Gjone
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

7.  Quantification of gastrin-producing cells (G cells) and parietal cells in relation to histopathological alterations in resected stomachs from patients with peptic ulcer disease.

Authors:  R Stave; K Elgjo; P Brandtzaeg
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

8.  G cell population of the gastric antrum, plasma gastrin, and gastric acid secretion in patients with and without duodenal ulcer.

Authors:  C M Royston; J Polak; S R Bloom; W M Cooke; R C Russell; A G Pearse; J Spencer; R B Welbourn; J H Baron
Journal:  Gut       Date:  1978-08       Impact factor: 23.059

9.  G-cell population and serum gastrin response to cimetidine-OXO test meal in relation to histopathological alterations in resected stomachs from patients with peptic ulcer disease.

Authors:  S Fujimoto; K Kimoto; H Inokuchi; K Kawai; S Yamashita; T Hattori
Journal:  Gastroenterol Jpn       Date:  1980-04

10.  Antral gastrin- and somatostatin-producing cells and intraluminal peptide secretion in normal subjects and duodenal ulcer patients with and without vagotomy.

Authors:  O Gutiérrez; E René; J P Accary; T Lehy; J P Laigneau; J A Chayvialle; S Bonfils
Journal:  Regul Pept       Date:  1986-04
View more
  3 in total

1.  Helicobacter pylori infection increases the risk of colorectal adenomas: cross-sectional study and meta-analysis.

Authors:  Sung Noh Hong; Seung Min Lee; Jeong Han Kim; Tae Yoon Lee; Jeong Hwan Kim; Won Hyeok Choe; Sun-Young Lee; Young Koog Cheon; In Kyung Sung; Hyung Seok Park; Chan Sup Shim
Journal:  Dig Dis Sci       Date:  2012-06-06       Impact factor: 3.199

2.  The Impact of Gastric Atrophy on the Incidence of Diabetes.

Authors:  Tse-Ya Yu; Jung-Nan Wei; Chun-Heng Kuo; Jyh-Ming Liou; Mao-Shin Lin; Shyang-Rong Shih; Cyue-Huei Hua; Yenh-Chen Hsein; Ya-Wen Hsu; Lee-Ming Chuang; Mei-Kuei Lee; Ching-Hsiang Hsiao; Ming-Shiang Wu; Hung-Yuan Li
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

3.  Molecular genotyping of anisakis larvae in Middle Eastern Japan and endoscopic evidence for preferential penetration of normal over atrophic mucosa.

Authors:  Toshio Arai; Nobuaki Akao; Takenori Seki; Takashi Kumagai; Hirofumi Ishikawa; Nobuo Ohta; Nobuto Hirata; So Nakaji; Kenji Yamauchi; Mitsuru Hirai; Toshiyasu Shiratori; Masayoshi Kobayashi; Hiroyuki Fujii; Eiji Ishii; Mikio Naito; Shin-ichi Saitoh; Toshikazu Yamaguchi; Nobumitsu Shibata; Masamune Shimo; Toshihiro Tokiwa
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.